Related Experiment Videos
Amlodipine-induced immune thrombocytopenia
E Garbe1, O Meyer, F Andersohn
1Institute of Clinical Pharmacology, Charité-University Medicine, Humboldt-University Berlin, Germany.
Vox Sanguinis
|February 27, 2004
Summary
Amlodipine, a common blood pressure medication, can trigger immune thrombocytopenia, a condition causing low platelets. This drug-induced condition mimics autoimmune disorders, highlighting the need for careful diagnosis.
Area of Science:
- Pharmacology
- Immunology
- Hematology
Background:
- Drug-induced thrombocytopenia is a rare but serious adverse effect.
- Amlodipine, a calcium-channel blocker, is frequently prescribed for hypertension.
- Immune thrombocytopenia (ITP) involves antibodies attacking platelets.
Observation:
- A 79-year-old patient experienced recurrent thrombocytopenic purpura.
- Symptoms reappeared after 10 years of continuous amlodipine treatment.
- Initial treatments with corticosteroids and immunoglobulin G provided temporary relief.
Findings:
- Amlodipine-dependent antibodies targeting platelets were identified in the patient's serum.
- Platelet counts normalized after amlodipine cessation.
- The patient recovered fully upon discontinuation of the suspected drug.
Implications:
- Amlodipine is a potential cause of drug-induced immune thrombocytopenia.
- This condition can be mistaken for primary autoimmune thrombocytopenia.
- Clinicians should consider amlodipine when evaluating drug-induced thrombocytopenia.